X-Rite Pantone has launched the latest addition to its eXact 2 range of portable spectrophotometers. The eXact 2 Basic is ...

X-Rite Pantone, announces eXact 2 Basic, the newest addition to the eXact 2 family of portable spectrophotometers. The eXact ...

X-Rite Pantone, the global authority in color standards and color science, announces eXact™ 2 Basic, the newest addition to the eXact 2 family of portable spectrophotometers. Available now, the new ...

Shares of Abbott Laboratories (ABT) lost ~7% to reach a 52-week low on Thursday after the MedTech giant lowered its full-year earnings outlook, indicating an impact from its recent acquisition of ...

ABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal brings Exact Sciences ...

MADISON, Wis. -- Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said. Madison-based Exact Sciences is known for its cancer detection technology such as ...

Announcement follows receipt of all regulatory clearances necessary for closing Transaction enables Abbott to enter and lead in fast-growing cancer screening and diagnostics segments, serving millions ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted ...

Recent Exact Sciences Corporation financials show accelerating revenue growth and stable margins, despite ongoing investments in screening and MRD. While EXAS maintains leadership in stool-based CRC ...

Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.